{"artifact":{"id":"experiment-exp-1105fe71-5dd5-4129-a4df-304f90d494bb","artifact_type":"experiment","entity_ids":"[\"SARS-CoV-2 spike protein\"]","title":"Monoclonal antibody half-life and protection study","quality_score":0.9,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"3308f905f6286cb43d81640b80b12a7c8c5228f76b8866b9a458e7cf76b658c6","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T03:39:55.447908"},"p_value":null,"protocol":"Administration of monoclonal antibodies (wild-type vs half-life-extended) to TKI mice followed by SARS-CoV-2 Omicron BA.2 challenge and assessment of lung viral loads","effect_size":null,"sample_size":null,"source_pmid":"40020261","extracted_at":"2026-04-09T20:39:55.416847","_schema_version":1,"experiment_type":"animal_model","success_criteria":"Significant reduction in lung viral loads with half-life-extended antibody treatment","expected_outcomes":"Half-life-extended antibody should show prolonged circulation and better protection compared to wild-type antibody","statistical_methods":null},"created_at":"2026-04-10T03:39:55-07:00","updated_at":"2026-04-10T03:39:55-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T03:39:55-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"6502cc8c-3ae7-4e65-8ef8-2fb7d23249e3","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"experiment-exp-8b475a0a-4cde-46b8-8835-58de11c1da4c","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-3f8198b1-5587-4e21-b24a-295dc81bdd35","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"paper-40020261","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"}],"incoming_links":[{"source_artifact_id":"experiment-exp-8b475a0a-4cde-46b8-8835-58de11c1da4c","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-3f8198b1-5587-4e21-b24a-295dc81bdd35","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"}],"current_artifact_id":"experiment-exp-1105fe71-5dd5-4129-a4df-304f90d494bb","is_canonical":true,"supersede_chain":["experiment-exp-1105fe71-5dd5-4129-a4df-304f90d494bb"]}